Physician Perspective on Incorporation of Oncology Patient Quality-of-Life, Fatigue, and Pain Assessment Into Clinical Practice

Por Hubbard, Joleen M., Grothey, Axel F., McWilliams, Robert R., Buckner, Jan C., Sloan, Jeff A.
Publicado no J Oncol Pract (2014)

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study

Por Pedersen, Katrina S., Kim, George P., Foster, Nathan R., Wang-Gillam, Andrea, Erlichman, Charles, McWilliams, Robert R.
Publicado no Invest New Drugs (2015)

Association of Mitotic Regulation Pathway Polymorphisms with Pancreatic Cancer Risk and Outcome

Por Couch, Fergus J., Wang, Xianshu, Bamlet, William R., de Andrade, Mariza, Petersen, Gloria M., McWilliams, Robert R.
Publicado em 2010

Association of Breast Cancer Susceptibility Variants with Risk of Pancreatic Cancer

Por Couch, Fergus J., Wang, Xianshu, McWilliams, Robert R., Bamlet, William R., de Andrade, Mariza, Petersen, Gloria M.
Publicado em 2009

Association of Family History of Specific Cancers With a Younger Age of Onset of Pancreatic Adenocarcinoma

Por McWILLIAMS, ROBERT R., BAMLET, WILLIAM R., RABE, KARI G., OLSON, JANET E., de ANDRADE, MARIZA, PETERSEN, GLORIA M.
Publicado em 2006

Nucleotide Excision Repair Pathway Polymorphisms and Pancreatic Cancer Risk: Evidence for role of MMS19L

Por McWilliams, Robert R., Bamlet, William R., de Andrade, Mariza, Rider, David N., Cunningham, Julie M., Petersen, Gloria M.
Publicado em 2009

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling

Por McWilliams, Robert R, Wieben, Eric D, Rabe, Kari G, Pedersen, Katrina S, Wu, Yanhong, Sicotte, Hugues, Petersen, Gloria M
Publicado em 2011

A Replication Study and Genome-wide Scan of Single Nucleotide Polymorphisms Associated with Pancreatic Cancer Risk and Overall Survival

Por Willis, Jason A., Olson, Sara H., Orlow, Irene, Mukherjee, Semanti, McWilliams, Robert R., Kurtz, Robert C., Klein, Robert J.
Publicado em 2012

Mitochondrial genetic polymorphisms do not predict survival in patients with pancreatic cancer

Por Halfdanarson, Thorvardur R., Wang, Liang, Bamlet, William R., de Andrade, Mariza, McWilliams, Robert R., Cunningham, Julie M., Petersen, Gloria M.
Publicado em 2008

Capecitabine and Temozolomide: Design, Implementation, and Preliminary Outcomes From a Pilot Project to Ensure Safe Prescribing of Oral Chemotherapy

Por Jatoi, Aminah, Smith, Emily L., Gunderson, Heidi D., Hartgers, Mindy L., Looker, Sherry A., Santana-Davila, Rafael, McWilliams, Robert R.
Publicado em 2010

EUS fine-needle pancreatic core biopsy can determine eligibility for tumor-agnostic immunotherapy

Por Gleeson, Ferga C., Levy, Michael J., Roden, Anja C., Boardman, Lisa A., Sinicrope, Frank A., McWilliams, Robert R., Zhang, Lizhi
Publicado no Endosc Int Open (2018)

Polymorphisms in DNA Repair Genes, Smoking, and Pancreatic Adenocarcinoma Risk

Por McWilliams, Robert R., Bamlet, William R., Cunningham, Julie M., Goode, Ellen L., de Andrade, Mariza, Boardman, Lisa A., Petersen, Gloria M.
Publicado em 2008

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutations and Risk for Pancreatic Adenocarcinoma

Por McWilliams, Robert R., Petersen, Gloria M., Rabe, Kari G., Holtegaard, Leonard M., Lynch, Pamela J., Bishop, Michele D., Highsmith, W. Edward
Publicado em 2010

Risk Factors for Pancreatic Neuroendocrine Tumors (PNETs): A Clinic-Based Case-Control study

Por Halfdanarson, Thorvardur R., Bamlet, William R., McWilliams, Robert R, Hobday, Timothy J., Burch, Patrick A., Rabe, Kari G., Petersen, Gloria M.
Publicado no Pancreas (2014)

Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history

Por Breitkopf, Carmen Radecki, Sinicrope, Pamela S, Rabe, Kari G, Brockman, Tabetha A, Patten, Christi A, McWilliams, Robert R, Ehlers, Shawna, Petersen, Gloria M
Publicado em 2012

Pre-Appointment Testing for BRAF/KIT Mutation in Advanced Melanoma: A Model in Molecular Data Delivery for Individualized Medicine

Por Mounajjed, Taofic, Brown, Char. L., Stern, Therese K., Bjorheim, Annette M., Bridgeman, Andrew J., Rumilla, Kandelaria M., McWilliams, Robert R., Flotte, Thomas J.
Publicado no Hum Pathol (2014)

Phase I Trial of a Pathotropic Retroviral Vector Expressing a Cytocidal Cyclin G1 Construct (Rexin-G) in Patients With Advanced Pancreatic Cancer

Por Galanis, Evanthia, Carlson, Stephanie K, Foster, Nathan R, Lowe, Val, Quevedo, Fernando, McWilliams, Robert R, Grothey, Axel, Jatoi, Aminah, Alberts, Steven R, Rubin, Joseph
Publicado em 2008

Obesity Adversely Affects Survival in Pancreatic Cancer Patients

Por McWilliams, Robert R., Matsumoto, Martha E., Burch, Patrick A., Kim, George P., Halfdanarson, Thorvardur R., de Andrade, Mariza, Reid-Lombardo, Kaye, Bamlet, William R.
Publicado em 2010

An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carc...

Por Berlin, Jordan D., Feng, Yang, Catalano, Paul, Abbruzzese, James L., Philip, Philip A., McWilliams, Robert R., Lowy, Andrew M., Benson, Al B., Blackstock, A. William
Publicado no Oncology (2017)

Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer

Por Li, Liang, Zhang, Jian-Wei, Jenkins, Gregory, Xie, Fang, Carlson, Erin E., Fridley, Brooke L., Bamlet, William R., Petersen, Gloria M., McWilliams, Robert R., Wang, Liewei
Publicado no Pharmacogenet Genomics (2016)